The Centers for Medicare & Medicaid Services (CMS) hit a significant roadblock in its obesity treatment strategy. Due to a... Read more
Category: Uncategorized
AbbVie’s Strategic Milestone: $1.4B Investment in AI-Integrated Manufacturing in North Carolina
AbbVie announced a landmark $1.4 billion investment to establish a 185-acre pharmaceutical manufacturing campus in Durham, North Carolina. This project... Read more
Merck Partners with Google in $1B Enterprise Deal to Drive “Agentic AI” Transformation
On April 22, 2026, Merck & Co. revealed a landmark partnership with Google Cloud valued at up to $1 billion.... Read more
Amneal Seizes “Golden Era” with $1.1B Acquisition of Kashiv BioSciences
On April 22, 2026, Amneal Pharmaceuticals announced its strategic acquisition of Kashiv BioSciences for $1.1 billion. This move positions Amneal... Read more
Novo Nordisk Targets Adolescent Diabetes Market Following Phase 3a Success
On April 23, 2026, Novo Nordisk unveiled positive data from its Phase 3a Pioneer Teens trial, positioning oral semaglutide to... Read more
High-Tech Healthcare on Pearl Island: Sun Group Inaugurates 5-Star Resort Hospital for APEC 2027
On April 23, 2026, Sun Group officially inaugurated Sun Hospital Phu Quoc following a rapid 8-month construction period. As the... Read more
Risks of Uncontrolled “Hand-carried” Goods: Threats to Infant Health
On April 23, 2026, the Vietnam Food Administration (VFA) issued a critical warning regarding the consumption of infant nutritional products... Read more
Vietnam – South Korea Medical Partnership: Expanding Links in Pharma, Food Safety, and High-Tech
On April 22, 2026, Minister of Health Dao Hong Lan chaired a high-level meeting and signed a Memorandum of Understanding... Read more
Strategic Setback for Merck: Lead Kidney Cancer Drug Fails Pivotal First-Line Trial
On April 21, 2026, Merck & Co. announced that its rapidly ascending drug, Welireg, failed to meet the primary endpoints... Read more









